Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.110
+0.010 (0.91%)
At close: May 16, 2025, 4:00 PM
1.120
+0.010 (0.90%)
After-hours: May 16, 2025, 7:49 PM EDT
Tenon Medical Stock Forecast
TNON's stock price has decreased by -84.05% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for Tenon Medical stock ranges from a low of $3.00 to a high of $24. The average analyst price target of $11.67 forecasts a 951.35% increase in the stock price over the next year.
Price Target: $11.67 (+951.35%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 9, 2025.
Analyst Ratings
The average analyst rating for Tenon Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | +170.27% | Apr 9, 2025 |
Maxim Group | Maxim Group | Strong Buy Maintains $22 → $8 | Strong Buy | Maintains | $22 → $8 | +620.72% | Nov 15, 2024 |
Benchmark | Benchmark | Buy Reiterates $24 | Buy | Reiterates | $24 | +2,062.16% | Aug 14, 2024 |
Benchmark | Benchmark | Buy Maintains $40 → $24 | Buy | Maintains | $40 → $24 | +2,062.16% | Apr 15, 2024 |
Benchmark | Benchmark | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +43,143.24% | Mar 10, 2023 |
Financial Forecast
Revenue This Year
6.30M
from 3.28M
Increased by 92.25%
Revenue Next Year
8.17M
from 6.30M
Increased by 29.65%
EPS This Year
-3.60
from -11.26
EPS Next Year
-1.17
from -3.60
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 9.5M | 8.9M | 14.6M |
Avg | 6.3M | 8.2M | 14.2M |
Low | 4.4M | 7.4M | 13.6M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 188.4% | 41.5% | 78.6% |
Avg | 92.2% | 29.7% | 73.5% |
Low | 34.9% | 17.1% | 66.7% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -2.10 | -1.00 | -0.68 |
Avg | -3.60 | -1.17 | -0.66 |
Low | -5.10 | -1.32 | -0.64 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.